In case you missed it, some of this week’s featured content includes a new podcast episode on the popularity of TikTok for dermatologists, FDA approvals for Soliton’s RAP device for cellulite and Galderma’s Restylane Defyne for chin augmentation, enrollment commencement for a food supplement and skin inflammation study, plus more.
This week’s edition of The Mainstream Patient features stories on sunscreen expiration, the link between dairy and acne, the skin barrier, how to manage retinization, plus more.
Soliton announced the FDA has cleared its Rapid Acoustic Pulse (RAP) device for short-term improvement in appearance of cellulite.
A proprietary food supplement designed to balance the gut microbiome and target the over production of skin cells will be examined in an upcoming consumer study that has recently announced participant enrollment.
Galderma announces the FDA-approval of HA dermal filler, Restylane Defyne for use in chin augmentation.
In this month's Cosmetic Conundrums column, Dermatology Times Chief Medical Editor Zoe Diana Draelos, MD, shares her tips for using cosmetics under face masks.
Angelo Landriscina, MD, discusses the recent rise in influence that TikTok has had over the dermatology industry.
Adam Friedman, MD, FAAD, outlined his five rules to ensure an effective atopic dermatitis management plan and discussed the current treatments available.